BRUXISM TREATMENT MARKET ANALYSIS

Bruxism Treatment MarketSize and Trends

Global bruxism treatment market is estimated to be valued at US$ 1,143.1 million in 2022 and is expected to exhibit a CAGR of 6.6% during the forecast period (2022-2030).

 Global Bruxism Treatment Market- Driver

Product approval for the bruxism treatment

Major companies operating in the global bruxism treatment market are focused on organic growth strategies such as product approval, which is expected to drive growth of the global bruxism treatment market over the forecast period. For instance, in November 2021, the U.S. Food and Drug Administration (FDA) had given SprintRay Inc., a company involved in digital dentistry and 3D printing solutions, approval to market its NightGuard Flex 3D printing resin as a Class II medical device in the U.S. NightGuard Flex resin is used in the treatment of bruxism.

The Increasing Prevalence of Bruxism

The increasing prevalence of bruxism, stress, and anxiety is expected to drive the market growth over the forecast period. For instance, on February 3, 2022, according to the report published by Up to Date, an evidence-based clinical resource company, bruxism affects approximately 15% to 40% of children and 8% to 10% of adults globally. According to the same source, in children, bruxism may occur as early as the appearance of the first teeth; the prevalence then increases to approximately 30% by the age of six years. In adults, the prevalence rates peak at about 12% in young adults and fall to 2% to 4% by age 60 years.

Figure 2. Global Bruxism Treatment Market Share (%), by Region, 2022